Back to Agenda
Session 4: Collaboration in the Industry
Session Chair(s)
James A. Boiani, JD, MS
Partner
Epstein Becker & Green, P.C., United States
Winifred Wu, MBA
President and Principal Advisor
Strategic Regulatory Partners, LLC, United States
Developing combination products often requires collaboration between drug, device, and biological product manufacturers. Partner relationships can range from joint development/joint ventures to working with key suppliers, to co-marketing. Business development professionals will share their best practices and challenges when collaborating with business partners. In this session, attendees will hear several scenarios of the diverse types of collaboration through presentations from multiple companies.
Speaker(s)
Collaboration in the Industry
Aaron Kemp
BD Medical, Pharmaceutical Systems, United States
Senior R&D Manager
Coordinating Quality Systems with Partners
Kirsten H. Paulson, MS, RAC
Pfizer, Inc., United States
Managing Successful Partnerships: From Novel Therapy Development Through Commercialization
Brenda K. Schultz, MBA, RN
Medtronic, United States
Senior Principal, Strategic Alliance Management
Building Strong Technical Relationships: A Lifelong Commitment
Sandy Koppenol, PhD, MS
Gilead Sciences, United States
Senior Research Scientist II
Supplier Selection Process for Devices in Combination Products
Christopher J. Kurtz
AbbVie, United States
Vice President, Drug Device Industrialization
Have an account?